Monosomy 7 Predisposition Syndromes Cn381368
A group of genetic conditions involving loss of chromosome 7 genetic material that raises the risk of blood disorders. Regular blood monitoring helps detect progression. Treatment focuses on managing leukemia when it develops.
Key facts at a glance
- ICD-10
- D64.9
- ICD-11
- 3A00.0
- Body system
- hematologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Bleeding tendency (e.g., petechiae, epistaxis)
Frequent infections
Generalized symptoms
(hematologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Pallor
(hematologic)Unexplained weight loss
(hematologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Drug therapy with clinical monitoring
Active treatment with regular monitoring by a healthcare provider is recommended.
Predisposition Syndrome Surveillance Program
Structured long-term monitoring program including regular blood work, bone marrow studies, and screening protocols to detect malignant transformation early.
Genetic Counseling and Family Planning Services
Comprehensive genetic counseling addressing inheritance patterns, prenatal testing options, and family communication strategies for hereditary monosomy 7 predisposition.
Additional treatment options
Low-Dose Chemoprevention
Consideration of low-dose azacitidine or similar agents in high-risk individuals to potentially delay or prevent myelodysplastic syndrome or leukemia development.
medicationImmunonutrition Support
Nutritional optimization with emphasis on immune-supporting nutrients, adequate protein intake, and avoidance of food safety risks given potential immunocompromise.
dietaryPreemptive Allogeneic Transplantation
Consideration of stem cell transplantation in identified high-risk individuals before overt malignancy develops, using affected family members as potential donors.
procedureWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Monosomy 7 Predisposition Syndromes Cn381368?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Monosomy 7 Predisposition Syndromes Cn381368. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy